Group One Trading’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,400
Closed -$1.15M 9300
2025
Q3
$1.15M Sell
4,400
-3,900
-47% -$948K ﹤0.01% 2881
2025
Q2
$1.82M Sell
8,300
-4,500
-35% -$962K ﹤0.01% 2230
2025
Q1
$2.87M Buy
12,800
+12,600
+6,300% +$3.47M 0.01% 1518
2024
Q4
$65.5K Buy
+200
New +$62.9K ﹤0.01% 4854
2024
Q3
Sell
-3,800
Closed -$1.25M 7456
2024
Q2
$1.25M Buy
3,800
+3,600
+1,800% +$1.27M ﹤0.01% 1808
2024
Q1
$79.1K Buy
+200
New +$74K ﹤0.01% 4347
2023
Q2
Sell
-2,600
Closed -$901K 8281
2023
Q1
$901K Sell
2,600
-100
-4% -$29.2K ﹤0.01% 2225
2022
Q4
$635K Buy
+2,700
New +$640K ﹤0.01% 2815
2022
Q3
Sell
-700
Closed -$212K 8342
2022
Q2
$212K Sell
700
-2,000
-74% -$651K ﹤0.01% 4261
2022
Q1
$1.11M Sell
2,700
-100
-4% -$39.1K ﹤0.01% 2975
2021
Q4
$1.31M Buy
2,800
+2,600
+1,300% +$1.12M ﹤0.01% 3059
2021
Q3
$85K Buy
200
+100
+100% +$42.2K ﹤0.01% 6066
2021
Q2
$36K Buy
+100
New +$33K ﹤0.01% 6839
2015
Q2
Sell
-10,000
Closed -$602K 5211
2015
Q1
$602K Buy
+10,000
New +$533K 0.01% 1462

Other funds holding WST

Group One Trading's WST Position: Q1 2026 in Review

Group One Trading sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 393 shares — an estimated $108K sold.

Group One Trading first reported a position in WST in Q2 2019 and held it in 12 quarters. The position peaked at $6.2M in Q2 2022. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Group One Trading reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 393 West Pharmaceutical shares in Q1 2026, an estimated $108K.
  • Group One Trading first reported a position in West Pharmaceutical in Q2 2019 and held it in 12 quarters.
  • Group One Trading's West Pharmaceutical position peaked at $6.2M in Q2 2022.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.